For Healthcare Professionals residing outside the UK and the USA
Univadis Independent Coverage Podcast Report Video Access additional resources

Highlights from ERS 2019

brought to you by
BI

It is that time of the year!

Thousands of healthcare professionals are gathering in Madrid, Spain, where one of the most popular scientific events in the field of respiratory medicine - the ERS congress - is taking place.

For those of you who may not have the chance to attend in person and benefit from the rich exchange of information, Boehringer Ingelheim and Univadis are joining forces to bring you the latest news and expert opinions in "real time".

Scroll down to access news articles and podcast sessions featuring some of the leading experts in respiratory medicine, who would like to share their ERS experience with you.

Come back every day for more!

Independent coverage by Univadis®

Load more

Sponsored content Boehringer Ingelheim


Report

INBUILD® meets primary endpoint - study evaluated nintedanib in patients across a range of progressive fibrosing interstitial lung diseases(1)

New data showed positive effect of nintedanib on slowing decline of lung function in a broad range of fibrosing interstitial lung diseases with a progressive phenotype1

Listen to daily podcast Boehringer Ingelheim


Podcast

ERS Congress 2019: Day Four

The future may be digital in ILD, pulmonary rehabilitation may be for more patients than first thought, plus why air pollution is likely to be on the respiratory agenda for the foreseeable future... All topics included in today's podcast highlights from the 2019 European Respiratory Society Congress, with discussions hosted by Doctor Mariel Slater, medical advisor at Boehringer Ingelheim.

Today's guests:
Doctor Frits Franssen, pulmonologist based in Maastricht, Holland with a field of interest in COPD and pulmonary rehabilitation.
Doctor Claudia Valenzuela, pulmonologist and specialist in ILD, based in the Hospital La Princesa Comunidad de Madrid.
Professor David Halpin, pulmonologist with an interest in asthma and COPD, based in the UK.

Please note: This is educational content intended for healthcare professionals. The opinions expressed are those of the experts, not of Boehringer Ingelheim.

Podcast

ERS Congress 2019: Day Three

Updates on progressive fibrosing ILD, cryobiopsy and e-cigarettes risks - all highlights of day three at the European Respiratory Society congress. Hosted by Doctor Mariel Slater, medical advisor at Boehringer Ingelheim.

Today's guests:
Professor David Halpin, pulmonologist with an interest in asthma and COPD, based in the UK.
Professor Michael Kreuter, pulmonologist from the University of Heidelberg in Germany.

Please note: This is educational content intended for healthcare professionals. The opinions expressed are those of the experts, not of Boehringer Ingelheim.

Podcast

ERS Congress 2019: Day Two

Is personalised medicine the future for respiratory treatment? That's one of many topics on lung experts minds during this year's European Respiratory Society congress in Madrid.

Doctor Mariel Slater, Medical Insider podcast host and Boehringer Ingelheim advisor, discovers key learnings from the day's sessions.

Today's guests:
Doctor Richard Russell, consultant physician with Southern Health in the UK and a senior clinical researcher for the University of Oxford.
Professor Vincent Cottin from the Claude Bernard University of Lyon in France with a special interest in interstitial lung disease, particularly fibrosis. 

Please note: This is educational content intended for healthcare professionals. The opinions expressed are those of the experts, not of Boehringer Ingelheim.

Load more

ERS congress view by the experts Boehringer Ingelheim


Report

ILD highlights from the ERS international congress 2019

Recent updates for the treatment of interstitial lung disease (ILD) were presented and discussed at the 2019 European Respiratory Society (ERS) annual congress, including analyses from the COLDICE study, the RELIEF trial, the INBUILD trial, and the SENSCIS trial. The objective of this report is to provide healthcare professionals with highlights from the presentations that are most relevant to their daily practice.

 

Download this congress report to get up to date treatment information on idiopathic pulmonary fibrosis, progressive fibrosing ILD, and systemic sclerosis-associated ILD

Download
Report

New directions in COPD

At the 2019 European Respiratory Society (ERS) annual congress held in Madrid, Spain, from 28 September – 2 October, new concepts were presented and discussed, including: advancements in pharmacologic treatments, the appropriate use of ICS therapy, treatment of exacerbations, as well as new insights on pulmonary rehabilitation, exercise capacity in patients with COPD and co-morbidities of COPD.

 

The objectives of this report are to inform interested healthcare professionals about the main COPD topics of discussion and highlights from the ERS 2019 and provide expert viewpoints on the clinical relevance of the new data for daily practice.

 

Download the Congress Report and  get up to date on  symptoms and treatment, exacerbations, role of eosinophils in guiding therapy, inhalers and inhalation, physical activity, and co-morbidities.

Download

Videos Boehringer Ingelheim


Load more

The content in this section is completely independent and is in no way affiliated with or coordinated by the European Respiratory Society (ERS).